Suchergebnisse - "Hadaschik, Boris A"

PubPharm (109)

1

Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer

enthalten in: Advances in therapy | 2019

von Chowdhury, S. | Oudard, S. | Uemura, H. | +10

2

Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

enthalten in: Advances in therapy | 2019

von Chowdhury, S. | Oudard, S. | Uemura, H. | +10

3

Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

enthalten in: Advances in therapy | 2019

von Chowdhury, S. | Oudard, S. | Uemura, H. | +10

4

Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer

enthalten in: Advances in therapy | 2019

von Chowdhury, S. | Oudard, S. | Uemura, H. | +10

5

Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

enthalten in: Advances in therapy | 2019

von Chowdhury, S. | Oudard, S. | Uemura, H. | +10

6

Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer

enthalten in: Advances in therapy | 2019

von Chowdhury, S. | Oudard, S. | Uemura, H. | +10

7

A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer

enthalten in: European urology oncology | 2019

von De Visschere, P. | Standaert, C. | Fütterer, J. | +8

CommentIn: Eur Urol Oncol. 2019 Feb;2(1):77-78. - PMID 30929847

8

Radiomic Machine Learning for Characterization of Prostate Lesions with MRI : Comparison to ADC Values

enthalten in: Radiology | 2018

von Bonekamp, D. | Kohl, S. | Wiesenfarth, M. | +14

CommentIn: Radiology. 2018 Oct;289(1):138-139. - PMID 30063185

9

Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer : an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Saad, F. | Cella, D. | Basch, E. | +12

CommentIn: Lancet Oncol. 2018 Oct;19(10):1275-1276. - PMID 30213450

10

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas

enthalten in: International journal of cancer | 2018

von Reis, H. | van der Vos, K. | Niedworok, C. | +34

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]